MMRF
RSX

Michelson Medical Research Foundation’s VanEck Russia ETF RSX Stock Holding History

Michelson Medical Research Foundation’s Portfolio RSX Stock Details RSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-105,000
Closed -$103K – 31
2022
Q4 		$103K Buy
+105,000
New +$593K 0.07% 31

Other funds holding RSX

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
MM
Main Management San Francisco, California $1.37B AUM 19.06% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
BCV
Banque Cantonale Vaudoise Lausanne, Switzerland $722M AUM 30.45% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
SSG
Summit Securities Group New York $1.05B AUM 36.17% 1-Year Est. Return

Michelson Medical Research Foundation's RSX Position: Q1 2023 in Review

Michelson Medical Research Foundation sold out of VanEck Russia ETF (RSX) in Q1 2023, closing a stake of 105,000 shares — an estimated $103K sold.

Michelson Medical Research Foundation first reported a position in RSX in Q4 2022 and held it in 1 quarter. The position peaked at $103K in Q4 2022. 35 funds tracked by Wall St. Rank hold RSX as of Q1 2023.

  • Michelson Medical Research Foundation reported no remaining VanEck Russia ETF position as of Q1 2023 after selling out during the quarter.
  • Michelson Medical Research Foundation sold 105,000 VanEck Russia ETF shares in Q1 2023, an estimated $103K.
  • Michelson Medical Research Foundation first reported a position in VanEck Russia ETF in Q4 2022 and held it in 1 quarter.
  • Michelson Medical Research Foundation's VanEck Russia ETF position peaked at $103K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held VanEck Russia ETF as of Q1 2023.

Based on Michelson Medical Research Foundation's 13F filing for Q1 2023, filed 15 May 2023.